Quest Diagnostics is committed to offering comprehensive support and information to help physicians successfully diagnose and manage patients with hepatitis C virus (HCV). In addition to extensive diagnostic screening tools, we also offer prognostic screening to help physicians predict the likelihood of therapeutic response and determine duration of treatment. Quest solutions include a full range of tests for resistance to direct-acting antiviral agents. Our FibroTest™/ActiTest™ panel is also available for non-invasive evaluation of liver fibrosis and inflammation activity in patients with chronic HCV infection. Quest’s array of testing options and seamless results reporting are designed to help physicians manage HCV at every step.